Ritter C L, Bennett K K, Fullerton N F, Beland F A, Malejka-Giganti D
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, USA.
Carcinogenesis. 1996 Nov;17(11):2411-8. doi: 10.1093/carcin/17.11.2411.
N-Hydroxy-N-2-fluorenylacetamide (N-OH-2-FAA) and its benzamide analogue N-OH-2-FBA are mammary gland carcinogens in the female Sprague-Dawley rat. Ovariectomy inhibits tumorigenicity of topically applied N-OH-2-FAA suggesting modulation of carcinogen-activating enzymes in the gland. This study concerned the activation of N-OH-2-FAA and N-OH-2-FBA by the mammary gland and liver, a chief site of metabolism, from 50-day-old female rats and effects on the activation of ovariectomy performed at 22 days of age. The levels of N-debenzolyation of N-OH-2-FBA to N-hydroxy-N-2-fluorenamine (N-OH-2-FA), catalyzed by microsomal carboxylesterases in mammary gland and liver were similar and increased 1.5- and 1.7-fold, respectively, by ovariectomy. N-Debenzoylating activity in cytosols of both tissues appeared to be partially of microsomal origin. Mammary gland cytosol contained N-, O- and N,O-acyltransferase activities at levels 40-50% those of liver. N-Acyltransferase activity was determined via acetyl coenzyme A (AcCoA)-dependent acetylation of 2-FA and a new assay, N-OH-2-FAA-dependent acetylation of 9-oxo-2-FA. The latter activity was decreased in mammary gland by ovariectomy. Microsomal N-acyltransferase activities were <36% those of cytosols. AcCoA-dependent binding of N-OH-2-[ring-[3H]FBA to DNA, catalyzed by cytosol, was consistent with a two-step activation of N-OH-2-FBA involving esterase-catalyzed N-debenzoylation to N-OH-2-FA and its O-acyltransferase-catalyzed acetylation to the electrophilic N-acetoxy-2-FA. O-Acetyltransfer by mammary gland appeared to be rate-limiting since ovariectomy-dependent increases in N-debenzoylation did not increase binding with S9 fraction. Little or no sulfotransferase-catalyzed binding of N-OH-2-[ring-3H]FBA-derived N-OH-2-[ring-3H]FA was detected in the liver or mammary gland cytosol, respectively. The level of binding of N-OH-2-[ring-3H]FAA to DNA catalyzed by cytosolic N,O-acyltransferase was decreased approximately 23% in mammary gland and increased 1.2-fold in liver by ovariectomy. 32P-Postlabeling analyses indicated a single adduct N-(deoxyguanosin-8-yl)-2-fluorenamine in DNA of both tissues 24 h after one intraperitoneal injection of N-OH-2-FBA or N-OH-2-FAA. Respective levels were 3.6- and 5.5-fold greater in liver than mammary gland. After ovariectomy, the adduct levels from N-OH-2-FBA increased 1.8-fold in mammary gland and from N-OH-2-FAA decreased approximately 50% in both tissues. Thus, the ovariectomy-dependent changes in levels of enzymes activating N-OH-2-FBA and N-OH-2-FAA were consistent with in vivo DNA adduct levels in the target mammary gland, but not in the liver.
N-羟基-N-2-芴基乙酰胺(N-OH-2-FAA)及其苯甲酰胺类似物N-OH-2-FBA是雌性斯普拉格-道利大鼠的乳腺致癌物。卵巢切除术可抑制局部应用N-OH-2-FAA的致瘤性,提示该腺体中致癌物激活酶受到调节。本研究关注50日龄雌性大鼠的乳腺和肝脏(主要代谢部位)对N-OH-2-FAA和N-OH-2-FBA的激活作用,以及对22日龄时进行卵巢切除术的激活作用的影响。乳腺和肝脏微粒体羧酸酯酶催化N-OH-2-FBA脱苯甲酰基生成N-羟基-N-2-芴胺(N-OH-2-FA)的水平相似,卵巢切除术分别使其增加了1.5倍和1.7倍。两种组织胞质溶胶中的N-脱苯甲酰基活性似乎部分源自微粒体。乳腺胞质溶胶中N-、O-和N,O-酰基转移酶活性水平为肝脏的40%-50%。N-酰基转移酶活性通过2-FA的乙酰辅酶A(AcCoA)依赖性乙酰化以及一种新的测定方法(9-氧代-2-FA的N-OH-2-FAA依赖性乙酰化)来确定。卵巢切除术使乳腺中的后一种活性降低。微粒体N-酰基转移酶活性低于胞质溶胶的36%。胞质溶胶催化的N-OH-2-[环-[3H]FBA与DNA的AcCoA依赖性结合与N-OH-2-FBA的两步激活一致,包括酯酶催化的N-脱苯甲酰基生成N-OH-2-FA及其O-酰基转移酶催化的乙酰化生成亲电子的N-乙酰氧基-2-FA。乳腺的O-乙酰转移似乎是限速步骤,因为卵巢切除术依赖性的N-脱苯甲酰基增加并未增加与S9组分的结合。在肝脏或乳腺胞质溶胶中分别未检测到或仅检测到少量磺基转移酶催化的N-OH-2-[环-3H]FBA衍生的N-OH-2-[环-3H]FA与DNA的结合。卵巢切除术使胞质溶胶N,O-酰基转移酶催化的N-OH-2-[环-3H]FAA与DNA的结合水平在乳腺中降低约23%,在肝脏中增加1.2倍。32P后标记分析表明,在一次腹腔注射N-OH-2-FBA或N-OH-2-FAA后24小时,两种组织的DNA中均有单一加合物N-(脱氧鸟苷-8-基)-2-芴胺。肝脏中的相应水平比乳腺高3.6倍和5.5倍。卵巢切除术后,N-OH-2-FBA产生的加合物水平在乳腺中增加1.8倍,N-OH-2-FAA产生的加合物水平在两种组织中均降低约50%。因此,卵巢切除术依赖性的激活N-OH-2-FBA和N-OH-2-FAA的酶水平变化与靶器官乳腺而非肝脏中的体内DNA加合物水平一致。